The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity
Open accessAbstract
Drug-induced liver injury (DILI) has become a leading cause of severe liver disease in Western countries and therefore poses a major clinical and regulatory challenge. Whereas previously drug-specific pathways leading to initial injury of liver cells were the main focus of mechanistic research and classifications, current concepts see these as initial upstream events and appreciate that subsequent common downstream pathways and their attenuation by drugs and other environmental and genetic factors also have a profound impact on the risk of an individual patient to develop overt liver disease. This review summarizes current mechanistic concepts of DILI in a 3-step model that limits its principle mechanisms to three main ways of initial injury, i.e. direct cell stress, direct mitochondrial impairment, and specific immune reactions. Subsequently, initial injury initiates further downstream events, i.e. direct and death receptor-mediated pathways leading to mitochondrial permeability transition, which then results in apoptotic or necrotic cell death. For all mechanisms, mitochondria play a central role in events leading to apoptotic vs. necrotic cell death. New treatment targets consequently focus on interference with downstream pathways that mediate injury and therefore determine the ultimate outcome of DILI. Genome wide and targeted pharmacogenetic as well as metabonomic approaches are now used in order to reach the key goals of a better understanding of mechanisms in hepatotoxicity, and to develop new strategies for its prediction and treatment. However, the complexity of interactions between genetic and environmental risk factors is considerable, and DILI therefore currently remains unpredictable for most hepatotoxins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Stress, Caloric Restriction, and Aging
Sohal, R. S., & Weindruch, R. (1996) · Science · doi:10.1126/science.273.5271.59 · Cited by 3,131
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043 · cited 1×
“Genome wide association studies that analyze several hundred thousand single nucleotide polymorphisms (SNPs) per patient have now become technically and economically feasible and have been successfully used for the identification of genetic risk factors even of rare adverse drug reactions in large phase III clinical t…”
MethodLeist, M., Single, B., Castoldi, A. F., Kühnle, S., & Nicotera, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1481 · Cited by 1,871
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380
Slee, E. A., Adrain, C., & Martin, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008363200 · Cited by 1,115
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen
Chan, K., Han, X.-D., & Kan, Y. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081082098 · Cited by 770
Enomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 685
Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. A., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 670
Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)
DeLeve, L. D., Shulman, H. M., & McDonald, G. B. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-23204 · Cited by 664
A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups
Kalgutkar, A., Gardner, I., Obach, R., Shaffer, C., Callegari, E., Henne, K., Mutlib, A., Dalvie, D., Lee, J., Nakai, Y., et al. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021799 · Cited by 616
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Self-citationDifferential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22532 · Cited by 580
Cellular and Molecular Mechanisms of Liver Injury
Malhi, H., & Gores, G. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.002 · Cited by 560
Rodrigues, C. M., Fan, G., Ma, X., Kren, B. T., & Steer, C. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1325 · Cited by 520
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women
Ibdah, J. A., Bennett, M. J., Rinaldo, P., Zhao, Y., Gibson, B., Sims, H. F., & Strauss, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402204 · Cited by 496
C-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity
Gunawan, B. K., Liu, Z., Han, D., Hanawa, N., Gaarde, W. A., & Kaplowitz, N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.045 · Cited by 471
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Lai, S.-L., Yang, S.-Y., Chang, F.-Y., & Lee, S.-D. (2002) · Hepatology · doi:10.1053/jhep.2002.32102 · Cited by 432
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced Hepatitis
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Chang, S.-C., Chiang, C.-H., Chang, F.-Y., & Lee, S.-D. (2003) · Hepatology · doi:10.1053/jhep.2003.50144 · Cited by 426
Mitochondrial Dysfunction in the Pathogenesis of Necrotic and Apoptotic Cell Death
Lemasters, J. J., Qian, T., Bradham, C. A., Brenner, D. A., Cascio, W. E., Trost, L. C., Nishimura, Y., Nieminen, A.-L., & Herman, B. (1999) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1005419617371 · Cited by 407
Langguth, H. S., & Benet, L. Z. (1992) · Drug Metabolism Reviews · doi:10.3109/03602539208996289 · Cited by 407
Mitochondria in Steatohepatitis
Pessayre, D., Berson, A., Fromenty, B., & Mansouri, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12929 · Cited by 391
Acute Liver Failure in the United States
(2003) · Seminars in Liver Disease · doi:10.1055/s-2003-42641 · Cited by 387
Formigli, L., Papucci, L., Tani, A., Schiavone, N., Tempestini, A., Orlandini, G. E., Capaccioli, S., & Zecchi Orlandini, S. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200001)182:1<41::aid-jcp5>3.0.co;2-7 · Cited by 370
Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R., Kullak-Ublick, G. A., Meier, P. J., & Pauli-Magnus, C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230418.28091.76 · Cited by 339
Self-citationThe Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2008) · Toxicology · doi:10.1016/j.tox.2007.10.029 · Cited by 329
Neutrophil depletion protects against murine acetaminophen hepatotoxicity†‡
Liu, Z., Han, D., Gunawan, B., & Kaplowitz, N. (2006) · Hepatology · doi:10.1002/hep.21175 · Cited by 324
Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2
Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D. U., Pham, C. G., Nelsbach, A. H., Melis, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1093 · Cited by 321
Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR
Zhang, J., Huang, W., Chua, S. S., Wei, P., & Moore, D. D. (2002) · Science · doi:10.1126/science.1073502 · Cited by 316
Andrade, R. J., Lucena, I. M., Kaplowitz, N., García-Muņoz, B., Borraz, Y., Pachkoria, K., García-Cortés, M., Fernández, C. M., Pelaez, G., Rodrigo, L., et al. (2006) · Hepatology · doi:10.1002/hep.21424 · Cited by 309
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen
Laskin, D. L., Gardner, C. R., Price, V. F., & Jollow, D. J. (1995) · Hepatology · doi:10.1002/hep.1840210424 · Cited by 290
Drug-induced liver injury: Summary of a single topic clinical research conference
Watkins, P. B., & Seeff, L. B. (2006) · Hepatology · doi:10.1002/hep.21095 · Cited by 279
Hepatotoxicity due to mitochondrial dysfunction
Pessayre, D., Mansouri, A., Haouzi, D., & Fromenty, B. (1999) · Cell Biology and Toxicology · doi:10.1023/a:1007649815992 · Cited by 274
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
Self-citationDrug-Induced Liver Disorders: Implications for Drug Development and Regulation
Kaplowitz, N. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00001 · Cited by 260
Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity.
Lauterburg, B. H., & Velez, M. E. (1988) · Gut · doi:10.1136/gut.29.9.1153 · Cited by 260
Tissue Repair: An Important Determinant of Final Outcome of Toxicant-Induced Injury
Mehendale, H. M. (2005) · Toxicologic Pathology · doi:10.1080/01926230590881808 · Cited by 233
Mitochondrial abnormalities—A link to idiosyncratic drug hepatotoxicity?
Boelsterli, U. A., & Lim, P. L. K. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.013 · Cited by 232
Botla, R., Spivey, J. R., Aguilar, H., Bronk, S. F., & Gores, G. J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24517-7 · Cited by 228
Mansouri, A., Demeilliers, C., Amsellem, S., Pessayre, D., & Fromenty, B. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29435-0 · Cited by 228
A pivotal involvement of IFN‐' in the pathogenesis of acetaminophen‐induced acute liver injury
Ishida, Y., Kondo, T., Ohshima, T., Fujiwara, H., Iwakura, Y., & Mukaida, N. (2002) · The FASEB Journal · doi:10.1096/fj.02-0046com · Cited by 226
Aithal, G. P., Ramsay, L., Daly, A. K., Sonchit, N., Leathart, J. B. S., Alexander, G., Kenna, G. J., Caldwell, J., & Day, C. P. (2004) · Hepatology · doi:10.1002/hep.20205 · Cited by 216
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy
Dixon, P. H., van Mil, S. W. C., Chambers, J., Strautnieks, S., Thompson, R. J., Lammert, F., Kubitz, R., Keitel, V, Glantz, A., Mattsson, L.-Å., et al. (2009) · Gut · doi:10.1136/gut.2008.159541 · Cited by 215
Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions
Rieder, M. J., Shear, N. H., Kanee, A., Tang, B. K., & Spielberg, S. P. (1991) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1991.3 · Cited by 213
Huang, Y.-S., Su, W.-J., Huang, Y.-H., Chen, C.-Y., Chang, F.-Y., Lin, H.-C., & Lee, S.-D. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.009 · Cited by 212
Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice
Goldring, C. E. P., Kitteringham, N. R., Elsby, R., Randle, L. E., Clement, Y. N., Williams, D. P., McMahon, M., Hayes, J. D., Itoh, K., Yamamoto, M., et al. (2004) · Hepatology · doi:10.1002/hep.20183 · Cited by 207
Schoepfer, A. M., Engel, A., Fattinger, K., Marbet, U. A., Criblez, D., Reichen, J., Zimmermann, A., & Oneta, C. M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.014 · Cited by 189
Nagai, H., Matsumaru, K., Feng, G., & Kaplowitz, N. (2002) · Hepatology · doi:10.1053/jhep.2002.33995 · Cited by 186
Mechanisms of benzarone and benzbromarone‐induced hepatic toxicity†
Kaufmann, P., Török, M., Hänni, A., Roberts, P., Gasser, R., & Krähenbühl, S. (2005) · Hepatology · doi:10.1002/hep.20634 · Cited by 184
Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure
Henderson, N. C., Pollock, K. J., Frew, J., Mackinnon, A. C., Flavell, R. A., Davis, R. J., Sethi, T., & Simpson, K. J. (2007) · Gut · doi:10.1136/gut.2006.104372 · Cited by 182
Enterohepatic transport of bile salts and genetics of cholestasis
Pauli-Magnus, C., Stieger, B., Meier, Y., Kullak-Ublick, G. A., & Meier, P. J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.017 · Cited by 175
Self-citationHepatitis induced by Kava (Piper methysticum rhizoma)
Stickel, F., Baumüller, H.-M., Seitz, K., Vasilakis, D., Seitz, G., Seitz, H. K., & Schuppan, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00175-2 · Cited by 175
Safety of Newly Approved Drugs: Implications for Prescribing
Temple, R. J., & Himmel, M. H. (2002) · JAMA · doi:10.1001/jama.287.17.2273 · Cited by 173
Latchoumycandane, C., Goh, C. W., Ong, M. M. K., & Boelsterli, U. A. (2007) · Hepatology · doi:10.1002/hep.21475 · Cited by 167
Meier, Y., Zodan, T., Lang, C., Zimmermann, R., Kullak-Ublick, G. A., Meier, P. J., Stieger, B., & Pauli-Magnus, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.38 · Cited by 165
Self-citationIdentification of polymorphic antioxidant response elements in the human genome
Wang, X., Tomso, D. J., Chorley, B. N., Cho, H.-Y., Cheung, V. G., Kleeberger, S. R., & Bell, D. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm066 · Cited by 165
Mihm, S., Galter, D., & Dröge, W. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781927 · Cited by 164
Vendemiale, G., Grattagliano, I., Caraceni, P., Caraccio, G., Domenicali, M., Dall'Agata, M., Trevisani, F., Guerrieri, F., Bernardi, M., & Altomare, E. (2001) · Hepatology · doi:10.1053/jhep.2001.23060 · Cited by 160
Self-citationMechanisms of NSAID-Induced Hepatotoxicity: Focus on Nimesulide
Boelsterli, U. A. (2002) · Drug Safety · doi:10.2165/00002018-200225090-00003 · Cited by 159
Deng, X., Stachlewitz, R. F., Liguori, M. J., Blomme, E. A. G., Waring, J. F., Luyendyk, J. P., Maddox, J. F., Ganey, P. E., & Roth, R. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110247 · Cited by 157
Andrade, R. J., Lucena, M. I., Alonso, A. O., García‐Cortés, M., García-Ruiz, E., Benitez, R. A., Fernández, C. M. A., Peláez, G. I. C., Romero, M., Corpas, R., et al. (2004) · Hepatology · doi:10.1002/hep.20215 · Cited by 154
Matsumaru, K., Ji, C., & Kaplowitz, N. (2003) · Hepatology · doi:10.1053/jhep.2003.50230 · Cited by 143
Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults
Thummel, K. E., Slattery, J. T., Ro, H., Chien, J. Y., Nelson, S. D., Lown, K. E., & Watkins, P. B. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106574 · Cited by 142
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
Act, A. (2008) · Cited by 142
Feldmann, G., Haouzi, D., Moreau, A., Durand‐Schneider, A., Bringuier, A. F., Berson, A., Mansouri, A., Fau, D., & Pessayre, D. (2000) · Hepatology · doi:10.1002/hep.510310318 · Cited by 138
Shayiq, R. M., Roberts, D. W., Rothstein, K. D., SNAWDER, J. E., Benson, W., Ma, X., & Black, M. (1999) · Hepatology · doi:10.1002/hep.510290241 · Cited by 135
Drug-induced liver injury network (DILIN)
Hoofnagle, J. H. (2004) · Hepatology · doi:10.1002/hep.1840400403 · Cited by 134
The hepatotoxic metabolite of acetaminophen directly activates the Keap1‐Nrf2 cell defense system†
Copple, I. M., Goldring, C. E., Jenkins, R. E., Chia, A. J. L., Randle, L. E., Hayes, J. D., Kitteringham, N. R., & Park, B. K. (2008) · Hepatology · doi:10.1002/hep.22472 · Cited by 132
The Danger Hypothesis Applied to Idiosyncratic Drug Reactions
Li, J., & Uetrecht, J. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_18 · Cited by 130
Hepatocellular Toxicity and Pharmacological Effect of Amiodarone and Amiodarone Derivatives
Waldhauser, K., Török, M., Ha, H.-R., Thomet, U., Konrad, D., Brecht, K., Folláth, F., & Krähenbühl, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108993 · Cited by 129
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis
Robin, M., Roy, M. L., Descatoire, V., & Pessayre, D. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82329-x · Cited by 129
Drug-induced liver injury: Hy’s rule revisited
BJORNSSON, E. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.02.012 · Cited by 128
Combined glutathione-S -transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity
Simon, T. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104944 · Cited by 122
Seeff, L. B. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.005 · Cited by 120
Mechanisms of Hepatic Transport of Drugs: Implications for Cholestatic Drug Reactions
Bohan, A., & Boyer, J. L. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30099 · Cited by 117
Role of innate immunity in acetaminophen-induced hepatotoxicity
Liu, Z., & Kaplowitz, N. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.4.493 · Cited by 117
Njoku, D. B., Greenberg, R. S., Bourdi, M., Borkowf, C. B., Dake, E. M., Martin, J. L., & Pohl, L. R. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200202000-00003 · Cited by 114
Ishida, Y., Kondo, T., Tsuneyama, K., Lu, P., Takayasu, T., & Mukaida, N. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403152 · Cited by 108
Haouzi, D., Lekéhal, M., Moreau, A., Moulis, C., Feldmann, G., Robin, M., Lettéron, P., Fau, D., & Pessayre, D. (2000) · Hepatology · doi:10.1053/jhep.2000.9034 · Cited by 108
Hepatotoxic slimming aids and other herbal hepatotoxins
Chitturi, S., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05310.x · Cited by 101
Deschamps, D., Fisch, C., Fromenty, B., Berson, A., Degott, C., & Pessayre, D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20562-6 · Cited by 101
Ginn‐Pease, M. E., & Whisler, R. L. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1416 · Cited by 99
Vendemiale, G., Grattagliano, I., Altomare, E., Turturro, N., & GUERRIERI, F. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00414-5 · Cited by 90
Self-citationStrauss, A. W., Bennett, M. J., Rinaldo, P., Sims, H. F., O'Brien, L. K., Zhao, Y., Gibson, B., & Ibdah, J. A. (1999) · Seminars in Perinatology · doi:10.1016/s0146-0005(99)80044-5 · Cited by 89
Hepatotoxicity Associated with Antiretroviral Therapy Containing HIV-1 Protease Inhibitors
Sulkowski, M. (2003) · Seminars in Liver Disease · doi:10.1055/s-2003-39949 · Cited by 87
Hepatic NKT cells: friend or foe?
Swain, M. G. (2008) · Clinical Science · doi:10.1042/cs20070328 · Cited by 80
The danger hypothesis applied to idiosyncratic drug reactions
Séguin, B., & Uetrecht, J. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200308000-00001 · Cited by 80
Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia
Russmann, S., Barguil, Y., Cabalion, P., Kritsanida, M., Duhet, D., & Lauterburg, B. H. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200309000-00015 · Cited by 77
Self-citationLakehal, F., Dansette, P. M., Becquemont, L., Lasnier, E., Delelo, R., Balladur, P., Poupon, R. Y., Beaune, P. H., & Housset, C. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002435 · Cited by 76
Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes
Wang, T., Shankar, K., Ronis, M. J. J., & Mehendale, H. M. (2007) · Critical Reviews in Toxicology · doi:10.1080/10408440701215100 · Cited by 73
Vendemiale, G., GUERRIERI, F., Grattagliano, I., Didonna, D., Muolo, L., & Altomare, E. (1995) · Hepatology · doi:10.1002/hep.1840210532 · Cited by 65
Self-citationNonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity
Donthamsetty, S., Bhave, V., Mitra, M. S., Latendresse, J. R., & Mehendale, H. M. (2007) · Hepatology · doi:10.1002/hep.21530 · Cited by 63
Pessayre, D., Haouzi, D., Fau, D., Robin, M. A., Mansouri, A., & Berson, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80360-2 · Cited by 56
Apte, U. M., Limaye, P. B., Ramaiah, S. K., Vaidya, V. S., Bucci, T. J., Warbritton, A., & Mehendale, H. M. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.2.448 · Cited by 56
Regulation of Hepatic Drug Metabolism: Role of the Nuclear Receptors PXR and CAR
Liddle, C., & Goodwin, B. J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30098 · Cited by 54
Decreased glutathione in patients with anorexia nervosa. Risk factor for toxic liver injury?
Zenger, F., Russmann, S., Junker, E., Wüthrich, C., Bui, M. H., & Lauterburg, B. H. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601772 · Cited by 53
Self-citationHigh hepatic glutathione stores alleviate Fas-induced apoptosis in mice
Cazanave, S. C., Berson, A., Haouzi, D., Vadrot, N., Fau, D., Grodet, A., Lettéron, P., Feldmann, G., Benna, J. E., Fromenty, B., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.015 · Cited by 52
Nardo, B., Caraceni, P., Pasini, P., et al. (2001) · Transplantation · doi:10.1097/00007890-200106270-00018 · Cited by 51
Limaye, P. B., Bhave, V., Palkar, P. S., Apte, U. M., Sawant, S. P., Yu, S., Latendresse, J. R., Reddy, J. K., & Mehendale, H. M. (2006) · Hepatology · doi:10.1002/hep.21250 · Cited by 47
Papucci, L., Formigli, L., Schiavone, N., Tani, A., Donnini, M., Lapucci, A., Perna, F., Tempestini, A., Witort, E. J., Morganti, M., et al. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0872-z · Cited by 45
Biour, M., Poupon, R. Y., Grangé, J., & Chazouillères, O. (2000) · PubMed · Cited by 44
Halothane-lnduced Hepatic Disease
Touloukian, J., & Kaplowitz, N. (1981) · Seminars in Liver Disease · doi:10.1055/s-2008-1040726 · Cited by 34
Lee, Y. H., Boelsterli, U. A., Lin, Q., & Chung, M. C. M. (2008) · PROTEOMICS · doi:10.1002/pmic.200700795 · Cited by 32
Krähenbühl, S., Brauchli, Y. B., Kummer, O., Bodmer, M., Trendelenburg, M., Drewe, J., & Haschke, M. (2007) · Digestion · doi:10.1159/000111032 · Cited by 31
Rules and laws of drug hepatotoxicity
Kaplowitz, N. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1212 · Cited by 30
Russmann, S., Junker, E., & Lauterburg, B. H. (2002) · Hepatology · doi:10.1053/jhep.2002.36499 · Cited by 20
Self-citationGrattagliano, I., Lauterburg, B. H., Portincasa, P., Caruso, M. L., Vendemiale, G., Valentini, A. M., Palmieri, V. O., & Palasciano, G. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00317-9 · Cited by 19
Self-citationNjoku, D., Laster, M. J., Gong, D. H., Eger, E. I., Reed, G. F., & Martin, J. L. (1997) · Anesthesia & Analgesia · doi:10.1097/00000539-199701000-00031 · Cited by 18
Glutathione S -Transferase GSTT1 and GSTM1 Allozymes: Beyond Null Alleles
Agúndez, J. A. G., & Ladero, J. M. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.3.359 · Cited by 18
Association between body mass index and liver disorders: an epidemiological study
Meier, C. R., Krähenbühl, S., Schlienger, R. G., & Jick, H. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00298-2 · Cited by 16
Acute Liver Failure in the United States
Lee, W. M., Larson, A. M., Fontana, R., & Ostapowicz, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-12-200312160-00024 · Cited by 15
78 Mechanisms of benzarone and benzbromarone induced hepatic toxicity
Kaufmann, P., Török, M., Hänni, A., Gasser, R. B., & Krähenbühl, S. (2004) · Journal of Hepatology · doi:10.1016/s0168-8278(04)90078-5 · Cited by 9
Cited by
Shuhendler, A. J., Pu, K., Cui, L., Uetrecht, J. P., & Rao, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2838 · Cited by 623
Figueira, T. R., Barros, M. H., Camargo, A. A., Castilho, R. F., Ferreira, J. C. B., Kowaltowski, A. J., Sluse, F. E., Souza-Pinto, N. C., & Vercesi, A. E. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4729 · Cited by 419
Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347
Mechanisms of Immune-Mediated Liver Injury
Adams, D. H., Ju, C., Ramaiah, S. K., Uetrecht, J., & Jaeschke, H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq009 · Cited by 298
Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
Shah, R. R., Morganroth, J., & Shah, D. R. (2013) · Drug Safety · doi:10.1007/s40264-013-0048-4 · Cited by 252
Metadata
- Authors
- Russmann, S., Kullak-Ublick, G., & Grattagliano, I.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-08-01
- Volume
- 16
- Issue
- 23
- Pages
- 3041-3053
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2165311122
- Cited by
- 412
- References
- 117
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.